DE69620691D1 - Therapeutisches Mittel zur Behandlung der Hypercholesterinämie - Google Patents

Therapeutisches Mittel zur Behandlung der Hypercholesterinämie

Info

Publication number
DE69620691D1
DE69620691D1 DE69620691T DE69620691T DE69620691D1 DE 69620691 D1 DE69620691 D1 DE 69620691D1 DE 69620691 T DE69620691 T DE 69620691T DE 69620691 T DE69620691 T DE 69620691T DE 69620691 D1 DE69620691 D1 DE 69620691D1
Authority
DE
Germany
Prior art keywords
hypercholesterolemia
treatment
therapeutic agent
therapeutic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69620691T
Other languages
English (en)
Other versions
DE69620691T2 (de
Inventor
Mutsunori Fujiwara
Toru Hiyoshi
Shinzo Makita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69620691D1 publication Critical patent/DE69620691D1/de
Publication of DE69620691T2 publication Critical patent/DE69620691T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69620691T 1995-06-15 1996-06-12 Therapeutisches Mittel zur Behandlung der Hypercholesterinämie Expired - Fee Related DE69620691T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7172874A JP2750281B2 (ja) 1995-06-15 1995-06-15 高コレステロール血症治療剤

Publications (2)

Publication Number Publication Date
DE69620691D1 true DE69620691D1 (de) 2002-05-23
DE69620691T2 DE69620691T2 (de) 2002-11-21

Family

ID=15949916

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69620691T Expired - Fee Related DE69620691T2 (de) 1995-06-15 1996-06-12 Therapeutisches Mittel zur Behandlung der Hypercholesterinämie

Country Status (4)

Country Link
US (2) US5705526A (de)
EP (1) EP0759294B1 (de)
JP (1) JP2750281B2 (de)
DE (1) DE69620691T2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262109B1 (en) * 1995-12-22 2001-07-17 Henkel Corporation Methods of preventing and/or treating high serum levels of cholesterol and/or lipids
EP0793491B1 (de) * 1994-12-22 2003-05-02 Henkel Corporation Lycopen enthaltende pharmazeutische zusammensetzungen
AUPO693397A0 (en) * 1997-05-22 1997-06-12 Betatene Limited Carotenoid formulation
IL121112A (en) * 1997-06-19 2005-11-20 Lycored Natural Prod Ind Ltd Synergistic pharmaceutical or dietary compositionscomprising lycopene and vitamin e for preventing ldl oxidation
JP3903399B2 (ja) * 1997-09-25 2007-04-11 雪印乳業株式会社 乳幼児用栄養組成物
US7763276B1 (en) 1999-02-26 2010-07-27 Shionogi & Co., Ltd. Chewable soft capsules having improved administration properties and process for producing the same
ES2262658T3 (es) * 2000-05-30 2006-12-01 Societe Des Produits Nestle S.A. Composicion primaria que contiene un compuesto bioactivo lipofilo.
IL141038A (en) * 2001-01-23 2006-10-05 Lycored Natural Prod Ind Ltd Use of carotenoids for the preparation of substances for the treatment of high blood pressure
US7144433B2 (en) * 2001-03-22 2006-12-05 Oryxe Energy International, Inc. Method and composition for using organic, plant-derived, oil-extracted materials in fossil fuels for reduced emissions
GB0515035D0 (en) * 2005-07-21 2005-08-31 Cambridge Theranostics Ltd Treatment of atherosclerotic conditions
JP2007269631A (ja) * 2006-03-30 2007-10-18 Kagome Co Ltd 中性脂肪蓄積抑制剤
WO2007122382A2 (en) * 2006-04-13 2007-11-01 Cammedica Limited Lycopene for the treatment of metabolic dysfunction
EP1886584A1 (de) * 2006-08-08 2008-02-13 Indena S.P.A. Stabile, bioverfügbare Zusammensetzungen von Lycopeneisomeren für Haare und Haut
US8216619B2 (en) * 2006-08-08 2012-07-10 Indena S.P.A. Stable and bioavailable compositions of isomers of carotenoids for skin and hair
RU2317099C1 (ru) * 2006-08-29 2008-02-20 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Лечебно-профилактическое средство для восстановления нарушений половых функций, способ получения масла зародышей пшеницы и способ получения концентрата масла зародышей пшеницы для восстановления нарушений половых функций
GB201120772D0 (en) 2011-12-02 2012-01-11 Ip Science Ltd Cocoa-based food products
JP7105536B2 (ja) * 2016-10-05 2022-07-25 ポッカサッポロフード＆ビバレッジ株式会社 Ｐｃｓｋ９阻害剤及びコレステロール代謝改善用食品組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920834A (en) * 1970-07-10 1975-11-18 Hoffmann La Roche Light-screening compositions and method
US5290605A (en) * 1989-06-29 1994-03-01 Niva Shapira Sun-exposure nutritional supporting composition
JP2654529B2 (ja) * 1992-03-27 1997-09-17 大塚製薬株式会社 健康飲料組成物
JPH06157298A (ja) * 1992-11-26 1994-06-03 Otsuka Pharmaceut Co Ltd 注射用脂肪乳剤
IL103920A (en) * 1992-11-30 2000-07-26 Makhteshim Chem Works Ltd Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof
GB2274235B (en) * 1993-01-13 1996-06-26 Neo Life Company Of America Carotenoid food supplement
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
EP0793491B1 (de) * 1994-12-22 2003-05-02 Henkel Corporation Lycopen enthaltende pharmazeutische zusammensetzungen

Also Published As

Publication number Publication date
JP2750281B2 (ja) 1998-05-13
EP0759294B1 (de) 2002-04-17
DE69620691T2 (de) 2002-11-21
US5849787A (en) 1998-12-15
EP0759294A3 (de) 1999-12-01
EP0759294A2 (de) 1997-02-26
JPH092947A (ja) 1997-01-07
US5705526A (en) 1998-01-06

Similar Documents

Publication Publication Date Title
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
ATE308527T1 (de) Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DE69509544D1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
ATE252901T1 (de) Arzneimittel zur behandlung von entzündlichen herzkrankheiten
DE69630947D1 (de) Mittel zur schmerzbehandlung
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE275383T1 (de) Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
DE69838785D1 (de) Pharmazeutische mittel zur behandlung von zerebralen amyloidosis
NO991459L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69841550D1 (de) Behandlung von fibromyalgie und verwandten erkrankungen
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
ATE226071T1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz
NO984432D0 (no) FremgangsmÕte for behandling av migrenesmerte
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO982562D0 (no) Sammensetning for behandling av smerte

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee